SI1902050T1 - Oksazolidinonski derivati in njihova uporaba kot antibiotiki - Google Patents

Oksazolidinonski derivati in njihova uporaba kot antibiotiki

Info

Publication number
SI1902050T1
SI1902050T1 SI200630494T SI200630494T SI1902050T1 SI 1902050 T1 SI1902050 T1 SI 1902050T1 SI 200630494 T SI200630494 T SI 200630494T SI 200630494 T SI200630494 T SI 200630494T SI 1902050 T1 SI1902050 T1 SI 1902050T1
Authority
SI
Slovenia
Prior art keywords
antibiotics
oxazolidinone derivatives
oxazolidinone
derivatives
Prior art date
Application number
SI200630494T
Other languages
English (en)
Inventor
Montserrat Cano
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34982564&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1902050(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of SI1902050T1 publication Critical patent/SI1902050T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200630494T 2005-06-27 2006-06-26 Oksazolidinonski derivati in njihova uporaba kot antibiotiki SI1902050T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05105714A EP1745784A1 (en) 2005-06-27 2005-06-27 Oxazolidinone derivatives and use thereof as antibiotics
EP06763881A EP1902050B1 (en) 2005-06-27 2006-06-26 Oxazolidinone derivatives and use thereof as antibiotics

Publications (1)

Publication Number Publication Date
SI1902050T1 true SI1902050T1 (sl) 2010-01-29

Family

ID=34982564

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630494T SI1902050T1 (sl) 2005-06-27 2006-06-26 Oksazolidinonski derivati in njihova uporaba kot antibiotiki

Country Status (23)

Country Link
US (1) US7759351B2 (sl)
EP (2) EP1745784A1 (sl)
JP (1) JP2008543963A (sl)
KR (1) KR20080020696A (sl)
CN (1) CN101248067A (sl)
AR (1) AR054625A1 (sl)
AT (1) ATE442366T1 (sl)
AU (1) AU2006263880A1 (sl)
BR (1) BRPI0612559A2 (sl)
CA (1) CA2612969A1 (sl)
CY (1) CY1109544T1 (sl)
DE (1) DE602006009112D1 (sl)
DK (1) DK1902050T3 (sl)
ES (1) ES2333469T3 (sl)
HK (1) HK1116482A1 (sl)
MX (1) MX2007016329A (sl)
NO (1) NO20080536L (sl)
PL (1) PL1902050T3 (sl)
PT (1) PT1902050E (sl)
RU (1) RU2417223C2 (sl)
SI (1) SI1902050T1 (sl)
TW (1) TWI324603B (sl)
WO (1) WO2007000432A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8138191B2 (en) 2007-01-11 2012-03-20 Critical Outcome Technologies Inc. Inhibitor compounds and cancer treatment methods
WO2009079797A1 (en) 2007-12-26 2009-07-02 Critical Outcome Technologies, Inc. Compounds and method for treatment of cancer
AU2009318783A1 (en) 2008-11-20 2011-06-23 Panacea Biotec Ltd. Novel antimicrobials
CN102803224A (zh) 2009-06-26 2012-11-28 万能药生物有限公司 新的氮杂双环己烷类化合物
CA2999435A1 (en) 2010-04-01 2011-10-06 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv
EP3020710A4 (en) * 2013-07-11 2016-12-14 Consejo Superior De Investig Científicas (Csic) OXAZOLIDINONE DERIVATIVES AS PPAR LIGANDS
CN103420995B (zh) * 2013-09-07 2015-07-01 吉首大学 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途
CN104447730B (zh) * 2014-12-05 2017-11-07 广东东阳光药业有限公司 噁唑烷酮类化合物及其在药物中的应用
TWI614256B (zh) 2017-05-26 2018-02-11 合成四氫異喹啉噁唑烷的方法
KR102152445B1 (ko) * 2017-09-28 2020-09-04 주식회사 엘지화학 의약품 합성용 중간체 화합물의 제조 방법
CA3183397A1 (en) 2020-06-18 2021-12-23 Daryl C. Drummond Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
CN115466253A (zh) * 2021-06-16 2022-12-13 沈阳药科大学 含二硫代氨基甲酸酯结构的噁唑烷酮类化合物及其制备方法
CN113880821B (zh) * 2021-10-29 2024-03-12 南京碳硅人工智能生物医药技术研究院有限公司 一类双光子荧光探针对癫痫脑内次氯酸特征成像的荧光探针设计及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511688A (ja) * 2001-11-29 2005-04-28 メルク アンド カンパニー インコーポレーテッド シクロプロピル含有オキサゾリジノン抗生物質及びその誘導体
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
EP1620433A1 (en) * 2003-04-07 2006-02-01 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials

Also Published As

Publication number Publication date
DE602006009112D1 (de) 2009-10-22
NO20080536L (no) 2008-03-14
HK1116482A1 (en) 2008-12-24
ES2333469T3 (es) 2010-02-22
RU2008102597A (ru) 2009-08-10
ATE442366T1 (de) 2009-09-15
CA2612969A1 (en) 2007-01-04
EP1902050B1 (en) 2009-09-09
BRPI0612559A2 (pt) 2010-11-23
US7759351B2 (en) 2010-07-20
CY1109544T1 (el) 2014-08-13
EP1902050A1 (en) 2008-03-26
JP2008543963A (ja) 2008-12-04
KR20080020696A (ko) 2008-03-05
AU2006263880A1 (en) 2007-01-04
AR054625A1 (es) 2007-07-04
RU2417223C2 (ru) 2011-04-27
CN101248067A (zh) 2008-08-20
MX2007016329A (es) 2008-03-10
PL1902050T3 (pl) 2010-03-31
US20090062266A1 (en) 2009-03-05
TWI324603B (en) 2010-05-11
EP1745784A1 (en) 2007-01-24
WO2007000432A1 (en) 2007-01-04
PT1902050E (pt) 2009-11-27
TW200740800A (en) 2007-11-01
DK1902050T3 (da) 2010-01-04

Similar Documents

Publication Publication Date Title
HK1116482A1 (en) Oxazolidinone derivatives and use thereof as antibiotics
EP1971600A4 (en) ISOXASOLE DERIVATIVES AND THEIR USE
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
IL191160A0 (en) Pyridopyrazine derivatives and use thereof
ZA200803758B (en) Oxazole compound and pharmaceutical composition
EP2123644A4 (en) BENZOXAZEPINE DERIVATIVES AND THEIR USE
EP1861387A4 (en) NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
HK1118829A1 (en) Thiazole derivatives and use thereof
GB0512940D0 (en) Compounds and their use
ZA200710966B (en) 2-Amino-4-Phenylquinazoline derivatives and their use as HSP90 modulators
EP1951682A4 (en) NEW 2-AMINOPYRIMIDONE OR 2-AMINOPYRIDINONE DERIVATIVES AND THEIR USE
ZA200710105B (en) Thiazole derivatives and use thereof
IL190221A0 (en) Isoxazole derivatives
GB0520743D0 (en) Compounds and their use
GB0516069D0 (en) Pharmaceutical and use thereof
EP1737458A4 (en) R (-) - 11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF
IL188520A0 (en) N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives preparation and use thereof
EP1921066A4 (en) PYRIDYLPHENOL COMPOUND AND USE THEREOF
IL192820A0 (en) Novel compounds and use thereof
IL188241A0 (en) Cripowellins and synthetic derivatives thereof used as medicaments
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
AP2007004173A0 (en) An oxindole oxazolidinone as antibacterial agent
ZA200708862B (en) Novel oxadiazole derivatives and their medical use
AP2007004125A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives